Clinical Trial Update: Dexmedetomidine Cardiovascular Safety in Pediatric Burn Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the cardiovascular safety of dexmedetomidine for sedation in pediatric burn patients; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injuries

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Burns, Sedation | Phase 2 | Status: COMPLETED | Results posted: 2017-07-17